Current Extramural Funding
Listed below are the past, present, and pending grants awarded to the Cyclotron and Radiochemistry program.
Design and Development of Imaging Methods to Detect Cancer and Metastases
Grant Period: 2018–2021
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agency: Da Zen Theranostics, Inc.
Contract Number: SRA201805-0014
Developmental and HyperActive RAS Tumor SPORE
Grant Period: 2015–2020
Principal Investigator: Stephen Skapek, M.D.
Funding Agencies: Indiana University/National Institutes of Health
Grant Number: 1 U54 CA196519-01
Development of Human Tau Imaging Capability for PSP Research in North Texas
Grant Period: 2016–2019
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agency: Texas Health Presbyterian/Rainwater Foundation
Grant Number: 73415
Directing Immunotherapy with iPET
Grant Period: 2015–2020
Principal Investigator: James Brugarolas, M.D., Ph.D.
Funding Agency: V Foundation
Grant Number: FP00014359
Immune Checkpoint Targeted Immuno-PET to Identify Therapy-Induced Adaptive Resistance
Grant Period: 2019–2021
Principal Investigators: Xiankai Sun, Ph.D., Raquibul Hannan, M.D., Ph.D.
Funding Agency: Department of Defense
Grant Numbers: W81XWH-18-KCRP-TRPA/KC18021P1
Improving Contrast for Antibody-Based Tumor Detection Using PET
Grant Period: 2017–2019
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agencies: Texas A&M/Cancer Prevention Research Institute of Texas
Grant Number: RP160051
Radiotherapeutic Nanoseeds for Internal Radiation Therapy of Unresectable Solid Tumors
Grant Period: 2016–2019
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agencies: University of Texas at Arlington/National Institutes of Health
Grant Number: 1 R15 CA199019-01A1
Targeting Neuroendocrine Prostate Cancer with Small Molecule Drug Conjugates
Grant Period: 2019–2022
Principal Investigator: Ganesh Raj, M.D., Ph.D.
Funding Agency: Department of Defense
Grant Number: W81XWH-18-PCRP-IDA
Targeted ProInflammatory Prodrugs for the Immunotherapy of Kidney Cancer
Grant Period: 2019–2021
Principal Investigator: Hans Hammers, M.D., Ph.D.
Funding Agency: Department of Defense
Grant Number: W81XWH-18-KCRP-IDA
Turn on the Tumor Contrast in Lymph Node Metastases for Occult Disease Detection
Grant Period: 2018–2021
Principal Investigator: Jinming Gao, Ph.D.
Funding Agency: Cancer Prevention Research Institute of Texas
Grant Number: RP180343
UT Southwestern SPORE in Kidney Cancer: Core D–Translational Imaging Core
Grant Period: 2016–2021
Principal Investigator: James Brugarolas, M.D., Ph.D.
Funding Agency: National Institutes of Health
Grant Number: 1 P50 CA196516-01A1
Understanding Cellular Origins of Tumor Tracer Data in Non-Small Cell Lung Cancer
Grant Period: 2016–2017
Principal Investigator: Christopher Hensley, Ph.D.
Funding Agency: Radiological Society of North America
Grant Number: RMS1611
Mapping Acidic Tumor Microenvironment with Renal Clearable pH Nanoindicators
Grant Period: 2014–2017
Principal Investigator: Jer-Tsong Hsieh, Ph.D.
Funding Agency: Cancer Prevention Research Institute of Texas/University of Texas Dallas Subcontract
Grant Numbers: RP140544; 1402004
Molecular Innovations Toward Theranostics of Aggressive Prostate Cancer
Grant Period: 2012–2017
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agency: Department of Defense
Grant Number: W81XWH-12-1-0336-03
Multi-Layered Valency: A Novel Design of Peptidic Imaging Agents for αvβ6
Grant Period: 2012–2017
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agency: National Institute of Biomedical Imaging and Bioengineering/National Institutes of Health–SRI
Grant Number: 7 R01 EB014244-04
Noninvasive PET Assessment of Pancreatic Beta-Cell Mass and Function
Grant Period: 2012–2015
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agency: Juvenile Diabetes Research Foundation International
Grant Number: 37-2011-632
Acquisition of Biomedical Cyclotron and Development of Comprehensive Positron Emission Tomography Program at UT Southwestern for Cancer Research
Grant Period: 2011–2016
Principal Investigator: Xiankai Sun, Ph.D.
Funding Agency: Cancer Prevention Research Institute of Texas
Grant Number: RP110771
Engineering Anti-Phosphatidylserine Antibodies for Cancer Therapy
Grant Period: 2011–2016
Principal Investigators: Xiankai Sun, Ph.D., E. Sally Ward, Ph.D.
Funding Agency: Cancer Prevention Research Institute of Texas
Grant Number: RP110549
Noninvasive Assessment of Pancreatic Beta-Cell Mass
Grant Period: 2011–2016
Principal Investigators: Xiankai Sun, Ph.D., Orhan Öz, M.D., Ph.D.
Funding Agency: National Institutes of Health
Grant Number: 1 R01 DK092163-01
Non-Invasive Imaging of Pancreatic Beta Cells Using Novel GLP-1 Constructs
Grant Period: 2011–2012
Principal Investigator: Jung-Mo Ahn, Ph.D.
Funding Agency: Juvenile Diabetes Research Foundation International
Grant Numbers: 37-2011-20; OSP ID100466
Novel Approaches for Eradication of Circulating Breast Cancer Cells
Grant Period: 2011–2012
Principal Investigator: Fangyu Peng, M.D., Ph.D.
Funding Agency: Army/Department of Defense
Grant Number: W81XWH-11-1-0188
Targeting Aggressive Prostate Cancer with Novel Theranostic Nanomedicine
Grant Period: 2011–2017
Principal Investigator: Jer-Tsong Hsieh, Ph.D.
Funding Agency: National Institutes of Health
Grant Number: 5 R01 CA159144-05
Targeting Tumor Microenvironment for Cancer Imaging and Therapy: Renal Clearable and pH Responsive Gold Nanoparticles
Grant Period: 2011–2014
Principal Investigators: Jie Zheng, Ph.D., Xiankai Sun, Ph.D.
Funding Agency: Cancer Prevention Research Institute of Texas
Grant Number: RP120588